Atara Biotherapeutics (LTS:0HIY) YoY EBITDA Growth : 172.49% (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Atara Biotherapeutics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Atara Biotherapeutics's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 172.49%.

Atara Biotherapeutics's EBITDA per Share for the three months ended in Mar. 2025 was $3.76.

Atara Biotherapeutics YoY EBITDA Growth Historical Data

The historical data trend for Atara Biotherapeutics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atara Biotherapeutics YoY EBITDA Growth Chart

Atara Biotherapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

27.74

13.05

38.35

-15.27

83.89

Atara Biotherapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															70.10	83.57	83.45	92.64	172.49

Atara Biotherapeutics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Atara Biotherapeutics's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-10.116	-	-62.794)	/	\| -62.794 \|
=	83.89 %

Atara Biotherapeutics's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(3.762	-	-5.19)	/	\| -5.19 \|
=	172.49 %

Atara Biotherapeutics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Atara Biotherapeutics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Atara Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atara Biotherapeutics Inc (LTS:0HIY) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

ATRA:USA AT20:Germany

Address

1280 Rancho Conejo Boulevard, Suite 200, Thousand Oaks, CA, USA, 91320

Website

https://www.atarabio.com

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Atara Biotherapeutics Headlines

No Headlines